Comparing two pain medicines for laparoscopic surgery patients at high nausea risk
Part of Digestive system clinical trials.
This trial tests a new pain medicine (Tegileridine) against a standard one (Sufentanil) during laparoscopic surgery. It is for patients who have a high risk of nausea and vomiting after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are scheduled for a laparoscopic surgery (like gynecological or general surgery).
- You have a high risk of nausea and vomiting after surgery (Apfel score of 3 or more).
- You are not currently using a pain pump for after surgery.
- Your BMI is less than 30.
- You do not have severe liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a newer painkiller (oliceridine) causes less nausea after a specific type of brain surgery than the standard painkiller (sufentanil). If you are having CPA region surgery and will receive a patient-controlled pain pump, this study may help find a better option for managing pain with fewer side effects.
This study compares two pain medicines, oxycodone and sufentanil, given through a pump you control after a laparoscopic hysterectomy. The goal is to see which one provides better pain relief with fewer side effects.
This trial tests a new way to monitor pain during laparoscopic surgery. It may help your doctor adjust pain medicines to keep you comfortable.
This study compares two pain-relief medications—tegileridine and sufentanil—given after major abdominal surgery to see which works better for pain control and helps your stomach and bowels recover faster. You'll be randomly assigned to receive one of these medications.
This study compares two fast-acting pain medicines given during surgery to see which one provides better anesthesia and recovery. It may help if you are having a non-emergency surgery that is expected to last 1 to 4 hours and you are generally healthy.
This trial tests whether adding fentanyl or dexmedetomidine to a standard numbing medicine (bupivacaine) provides better pain relief after knee surgery. It may help find the best option for patients undergoing knee procedures like total knee replacement or ACL repair.
Hear when a new Postoperative Nausea and Vomiting (PONV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.